Neurocrine Bioscience buy Morgan Stanley
Start price
07.03.25
/
50%
€105.00
Target price
07.03.26
€138.30
Performance (%)
4.86%
Price
06.08.25
€110.10
Summary
This prediction is currently active. The BUY prediction by Morgan_Stanley shows slight gains of 4.86%. This prediction currently runs until 07.03.26. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Neurocrine Bioscience | -8.020% | -8.020% |
| iShares Core DAX® | -0.933% | 0.936% |
| iShares Nasdaq 100 | -2.152% | 3.580% |
| iShares Nikkei 225® | 0.021% | 1.387% |
| iShares S&P 500 | -2.296% | 2.847% |
Comments by Morgan_Stanley for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its "overweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $150.00 price target on the stock, down previously from $185.00.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Morgan_Stanley for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€112.45
31.07.25
31.07.25
€138.22
31.07.26
31.07.26
-2.09%
06.08.25
06.08.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€112.50
22.07.25
22.07.25
€128.31
22.07.26
22.07.26
-1.91%
06.08.25
06.08.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€148.00
04.02.25
04.02.25
€178.90
04.02.26
04.02.26
-25.61%
06.08.25
06.08.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€136.55
12.07.24
12.07.24
€155.89
12.07.25
12.07.25
-17.17%
13.07.25
13.07.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€124.65
12.06.24
12.06.24
€147.54
12.06.25
12.06.25
-14.64%
13.06.25
13.06.25